Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

PainChek

  • Home
  •  
  • PainChek



  • Most Read
  • Latest Comments
  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

  • TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    • News

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    • News

    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US

    It’s not often thought about but as we get older, our verbal capabilities deteriorate with age and for some, this can have a drastic impact on their health when unable to communicate the state of their wellbeing. Such issues for those who are non-verbal due to neurodegenerative diseases, however, may soon be solved for those

    Read More
    Public
  • From pain to gain: EPO grants PainChek patent in 20 European nations
    • News

    From pain to gain: EPO grants PainChek patent in 20 European nations

    Medical device company PainChek (ASX: PCK), developer of a smartphone-based pain assessment and monitoring application, has been granted a patent in 20 European nations by the European Patent Office (EPO).  The patent application is titled “A Pain Assessment Method and System” and allows PainChek to safeguard the intellectual property of its pain assessment and monitoring

    Read More
    Public
  • PainChek steps into the Japanese market, taps into the region’s massive ageing population
    • News

    PainChek steps into the Japanese market, taps into the region’s massive ageing population

    Japanese caretakers will soon be able to look at non-verbal babies’ and senior citizens’ faces and break down facial expressions to understand if they are in pain. Digital pain assessment app PainChek Limited (ASX: PCK) has announced that it is expanding its activities to Japan following its acceptance into the Japan External Trade Organisation (JETRO)

    Read More
    Public
  • PainChek expands across New Zealand with pain tech deployed to 24 aged care facilities
    • News

    PainChek expands across New Zealand with pain tech deployed to 24 aged care facilities

    Confident in their technology that can accurately assess a patient’s pain simply from a short video of their face, medtech company PainChek (ASX: PCK) has successfully converted a 6-month trial with one of New Zealand’s largest aged care operators into a full revenue-generating contract. The contract comes after Summerset Holdings (ASX: SNZ) trialled PainChek’s smartphone

    Read More
    Public
  • Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers

    Intelligent pain assessment company Painchek (ASX: PCK) is eager to become the new standard of care in aged care settings, today announcing that licensed agreements for their platform’s use now encompass 60% of Australian aged care providers. PainChek’s mobile based pain assessment tool uses AI and facial recognition software to objectively automate and quantify pain

    Read More
    Public
  • Painchek to launch infant pain assessment app in Europe and APAC
    • News

    Painchek to launch infant pain assessment app in Europe and APAC

    Worried parents across Europe and Asia Pacific will soon be able to know when their pre-verbal infants are feeling pain with medtech company PainChek (ASX: PCK) securing regulatory approval for their facial recognition app that assesses pain levels. Where infants cannot communicate their feelings, parents can take a quick smartphone video of the infant’s facial

    Read More
    Public
  • 1
  • 2

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.